Seattle biotech working on treating Alzheimer's raises $44M, filing shows
July 27, 2022 at 15:16 PM EDT
The funding follows a $23.1 million Series A round in January 2021.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.